Tianeptine: A novel strategy of psychopharmacological treatment of children with autistic disorder

Human Psychopharmacology

Volumn 18, Issue 5, 2003, Pages 389-393

  Niederhofer, Helmut ^a   Staffen, W ^b   Mair, A ^b  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b Christian Doppler Klinik   (Austria)

Author keywords

Autism; Behaviour; Tianeptine

Indexed keywords

CLONIDINE; DESIPRAMINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; PLACEBO; PSYCHOTROPIC AGENT; TIANEPTINE;

ADOLESCENT; ANGER; APPETITE DISORDER; ARTICLE; AUTISM; BEHAVIOR DISORDER; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVELOPMENTAL STAGE; DIAGNOSTIC TEST; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; EMOTIONAL DISORDER; EYE MOVEMENT; HEADACHE; HUMAN; IRRITABILITY; LANGUAGE DEVELOPMENT; PHYSICIAN; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; RATING SCALE; SHORT COURSE THERAPY; SLEEP DISORDER; SPEECH DISORDER; STEREOTYPY; STOMACH PAIN; TEACHER; THIRST; VERTIGO; VIDEORECORDING;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; MALE; THIAZEPINES;

EID: 0042312408     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.491     Document Type: Article

References (22)

1. Amman MG, Singh NN, Stewart AW, Field CJ. 1985. Psychometric characteristics of the Aberrant Behavior Checklist and Symptom Checklist. Am J Ment Def 99: 492-502.
2. Andres C. 2002. Molecular genetics and animal models in autistic disorder. Brain Res Bull 57: 109-119.
3. Birmaher B, Quintana H, Greenhill LL. 1988. Methylphenidate treatment of hyperactive autistic children. J Am Acad Child Adolese Psychiatry 27: 248-251.
4. Campbell M, Cohen IL, Anderson LT. 1951. Pharmacotherapy for autistic children, a summary of research. Can J Psychiatry 26: 265-273.
5. Campbell M, Fish B, David R, Shapiro T, Collins P, Koh C. 1972. Response to triiodothyronine and dextroamphetamine: a study of preschool schizophrenic children. J Autism Child Schizophr 2: 943-955.
6. Campbell M, Adams P, Perry R, Speneer RK, Overall JE. 1985. Tardive and withdrawal dyskinesia in autistic children: a prospective study. Psychopharmacol Bull 24: 251-255.
7. Cook EH. 1990. Autism: review of neurochemical investigation. Synapse 6: 292-308.
8. Costa E, Ravizza L, Barbaccia ML. 1986. Evaluation of current theories on the mode of action of antidepressants. In GABA and Mood Disorders: Experimental and Clinical Research, Bartholini G, Lloyd A, Morselli E (eds). Raven Press: New York; 9-21.
9. Dziedzicka-Wasylewska M, Rogoz Z, Skuza G, Dlaboga D, Maj J. 2002. Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2)/D(3) receptors. Behav Pharmacol 13: 127-138.
10. Gordon CT, Rapoport IL, Hamburger SD, State RC, Mannheim GB. 1992. Differential response of seven subjects with autistic disorder to clomipramine and desipramine. Am J Psychiatry 149: 363-366.
11. Hollingshead A, Redlich RC. 1958. Social Class and Mental Illness. John Wiley & Sons: New York.
12. Hunt R, Minderaa R, Cohen D. 1955. Clonidine benefits children with attention deficit disorder and hyperactivity: report of double blind placebo crossover therapeutic trial. J Am Acad Child Psychiatry 24: 617-629.
13. Jaselskis CA, Cook EH, Fleteher KE, Leventhal BL, 1992. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharm 5: 322-327.
14. Lake CR, Ziegler MG, Murphy DL. 1977. Increased norepinephrine levels and decreased dopaminehydroxylase activity in primary autism. Arch Gen Psychiatry 34: 553-556.
15. Mennini T, Mocaer E, Garattini S. 1987. Tianeptine, a selective enhancer of serotonin uptake in rat brain. Arch Pharmacol 33: 478-482.
16. National Institute of Mental Health. 1985. Special feature: rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21: 839.
17. Overall JE, Campbell M. 1988. Behavioral assessment of psychopathology in children: infantile autism. J Clin Psychol 44: 708-716.
18. Perry R, Campbell M, Adams P, Lynch N, Speneer EK. 1959. Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration. J Am Acad Child Adolesc Psychiatry 25: 57-92.
19. Rogoz Z, Skuza G, Dlaboga D, Maj J, Dziedzicka-Wasylewska M. 2001. Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system. Neuropsychopharmacology 41: 360-368.
20. Shaffer D, Gould M, Brasio E, et al. 1973. The Children's Global Assessment Scale (CGAS): adapted from Global Assessment Scale for Adults. Arch Gen Psychiatry 40: 1228-1231.
21. Strauss WL, Unis AS, Cowan C, Dawson G, Dager SR. 2002. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders. Am J Psych 159: 755-760.
22. Wagstaff AJ, Ormrod D, Spencer CM. 2001. Tianeptine: a review of its use in depressive disorders. CNS Drugs 15: 231-259.